Arrhythmia: Clinical Trials

6 trials for Arrhythmia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 31Completed 1

Follow Arrhythmia: new trials by email Literature Review of Arrhythmia trials Research Report on Arrhythmia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients
AZD2927, Placebo - Arrhythmia
Phase 2CompletedAstraZeneca202011-09-012012-11-27
Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly Patients
Docosahexaenoic acid (DHA), Placebo - Arrhythmia
Phase 2 / Phase 3CompletedCampus Bio-Medico University502008-06-012009-11-25
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Dialysate Magnesium (Concentration) - Chronic Kidney Disease, Arrhythmia
Phase 2CompletedUniversity of Michigan252005-11-012014-12-09
Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS
SSR149744C - Arrhythmia, Tachycardia, Ventricular
Phase 2CompletedSanofi1532005-06-012012-05-08
Antiarrhythmic Effects of N-3 Fatty Acids
dietary n-3 polyunsaturated fatty acids - Arrhythmia, Heart Diseases
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)1999-02-012016-02-18
Cardiac Arrhythmia Pilot Study (CAPS)
encainide, moricizine, flecainide - Arrhythmia, Cardiovascular Diseases
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)1982-09-012012-04-27

Narrower conditions

Arrhythmias, Cardiac (6)  ·  Heart Diseases (2)  ·  Tachycardia, Ventricular (2)  ·  Ventricular Fibrillation (2)  ·  Cardiovascular Diseases (1)  ·  Death, Sudden, Cardiac (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Cardiovascular Diseases (5)  ·  Heart Diseases (4)  ·  Cardiac Conduction System Disease (2)  ·  Tachycardia (2)  ·  Chronic Disease (1)  ·  Death (1)  ·  Death, Sudden (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Heart Arrest (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)

Interventions

AZD2927 (1)  ·  Docosahexaenoic Acids (1)  ·  Encainide (1)  ·  Flecainide (1)  ·  Imipramine (1)  ·  Moricizine (1)  ·  celivarone (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  AstraZeneca (1)  ·  Campus Bio-Medico University (1)  ·  Sanofi (1)  ·  University of Michigan (1)

Countries

Italy (2)  ·  United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Allan Barker (1)  ·  Craig Pratt (1)  ·  David Richardson (1)  ·  Francesco M Serino, MD (1)  ·  Giuseppe Rosano, MD (1)  ·  Hakan Walfridsson, MD, PHD (1)  ·  Israel Stein (1)  ·  J. Bigger (1)  ·  Lawrence Griffith (1)  ·  Marco Miceli, MD (1)  ·  Michael Sather (1)  ·  Panduranga S Rao, MD, DNB, MS (1)  ·  Pierre Theroux (1)  ·  Raffaele Antonelli Incalzi, MD (1)

Results publications

PMID 21978965

NIH funding

R01HL061682 (1)